Specifications TableSubject area*Applied Microbiology and Biotechnology*More specific subject area*Microencapsulated probiotics with low and medium viscosity sodium alginate prepared by vibration technology.*Type of data*Graph*How data was acquired*Probiotic microcapsules were manufactured used a Microencapsulator BÜCHI (Encapsulated B-390) and viability was obtained after filtration and dissolution in sodium citrate to release microcapsules and count CFU in supernatant according Olivares* et al.(2017) \[[@bib3]\].Data format*Raw and analyzed data.*Experimental factors*Viability of Lactobacillus casei expressed in* log *CFU/g spheres was determined according to Olivares* et al.(2017) \[[@bib1]\].Experimental features*A factorial design (3*^*3*^*) was carried out with two microencapsulator variables: \[frequency (*1000Hz, 3000Hz *and* 5000Hz*) and nozzle size (*450μm, 750μm *and* 1000μm*)\] and three different alginate concentrations (1%, 2% and 3%).*Data source location*Valparaíso, Chile.*Data accessibility*Data are included in this article and supplemental file.*Related research article*Olivares, A., Silva, P., Altamirano, C. 2017. Microencapsulation of probiotics by efficient vibration technology. Journal of Microencapsulation, 34 (7): 667--674. doi.org/10.1080/02652048.2017.1390005***Value of the Data**•The data present the importance of the alginate viscosity on the formation of gel beads for probiotics microencapsulation by vibration technology.•Help to identify the best microencapsulation variables.•Data of viability of *Lactobacillus casei* at low and medium viscosity sodium alginate presented can be used for choosing a correct gel matrix depending on its use.•The data can be easily replicated, mainly because the strain, matrix, and equipment used to prepare microcapsules are commercially available.

1. Data {#sec1}
=======

Viability of microencapsulated *Lactobacillus casei* at a different frequency of microencapsulation and at different nozzle size 450 μm, 750 μm, 1000 μm and at low and medium viscosity sodium alginate concentration are shown in [Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}, respectively. Data show 3 different alginate concentration, 1%, 2% and 3% (figures A, B, and C, respectively). The operational variables of the microencapsulation equipment can be modified to achieve a better target and these data represent the viability of *Lactobacillus casei* (log UFC/sphere). At 450 μm, viability range varied between 7.395 and 8.247 log CFU/spheres for three frequencies and low viscosity sodium alginate concentration, meanwhile at the same nozzle size range was between 7.131 and 8.530 log CFU/spheres for three frequencies medium viscosity sodium alginate concentration. At 750 μm, viability range varied between 7.019 and 7.469 log CFU/spheres for three frequencies and low viscosity sodium alginate concentration, meanwhile at the same nozzle size range was between 6.963 and 8.531 log CFU/spheres for three frequencies medium viscosity sodium alginate concentration. And at 1000 μm, viability range varied between 0.0 (at 3000 and 5000 Hz and concentration of 2%) and 7.845 log CFU/spheres for three frequencies and low viscosity sodium alginate concentration, meanwhile at the same nozzle size range was between 6.992 and 8.486 log CFU/spheres for three frequencies medium viscosity sodium alginate concentration. At low viscosity, the highest viability was obtained at a concentration of 3%, while at medium viscosity better viability was obtained at a level of 2% and for all the nozzles and frequencies studied, the viability was higher than 8.427 log CFU/spheres. The highest viability of the probiotics was at a 2% sodium alginate concentration (medium viscosity) and a frequency of 1000 Hz, and there was no significant difference (*P* \< 0.05) between the size nozzle (the maximum viability value was 8.531 log UFC/g spheres at 450 μm and were the smallest beads size).Fig. 1Viability of microencapsulated *Lactobacillus casei* at different frequency of microencapsulation and low viscosity alginate. **A**: alginate concentration 1%, **B**: alginate concentration 2%, **C**: alginate concentration 3%. (Nozzle size: ![](fx1.gif): 450 μm, ![](fx2.gif): 750 μm, ![](fx3.gif): 1000 μm). Different letters mean a significant difference (*P* \< 0.05) between the nozzle size in the same frequency group.Fig. 1Fig. 2Viability of microencapsulated *Lactobacillus casei* at different frequency of microencapsulation and medium viscosity alginate. **A**: alginate concentration 1%, **B**: alginate concentration 2%, **C**: alginate concentration 3%. (Nozzle size: ![](fx1.gif): 450 μm, ![](fx2.gif): 750 μm, ![](fx3.gif): 1000 μm). Different letters mean a significant difference (*P* \< 0.05) between the nozzle size in the same frequency group.Fig. 2

2. Experimental design, materials, and methods {#sec2}
==============================================

2.1. Materials {#sec2.1}
--------------

*Lactobacillus casei* (DSM 20011) were supplied by DSMZ-Germany and used in lyophilized form according Olivares et al. \[[@bib3]\].

Two kinds of alginic acid sodium salt from Sigma-Aldrich, St. Louis, MO, USA were used. Low viscosity (Sigma cod. A1112) with 4--12 cP and medium viscosity (Sigma cod. A2033) and grater than 2000 cP. A sophisticated microencapsulation technology developed by BÜCHI (Encapsulator B-390; CIENTEC Instrumentos Científicos, S.A. Chile) was used.

2.2. Microcapsules production {#sec2.2}
-----------------------------

Each sodium alginate solution (low and medium viscosity) was prepared at double of its concentration and then mixed at 1:1 ratio with a *Lactobacillus casei* solution (prepared at 5g/L with lyophilized powder with more than 10 log CFU/g).

To form microcapsules, BÜCHI Encapsulator B-390 were used. Nozzle size and frequency were changed for each assay. Flow rate was constant (20 mL/min) and controlled by pump injector. Voltage of 250 V was used \[[@bib2],[@bib3]\].

2.3. Microencapsulated cell count {#sec2.3}
---------------------------------

The microcapsules were dissolved in 50mM sodium citrate (pH 7.5) to release *Lactobacillus* cells into the supernatant for counting according Olivares et al. \[[@bib3]\].

2.4. Statistical analysis {#sec2.4}
-------------------------

The data are expressed as the mean ± standard deviation of triplicate experiments. The data was subjected to analysis of variance (ANOVA) to compare results and determine statistical significant difference (*P* \< 0.05).
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